Kağan GÜNGÖR,
Serkan ÖZTÜRK,
Bülent CAN,
Mehmet SARGIN
FASTING PLASMA C-PEPTIDE LEVEL PREDICTS THE RESPONSE OF GLUCAGON-LIKE PEPTIDE-1 AGONIST (EXENATIDE) ADD ON TO METFORMIN MONOTHERAPY IN OBESE TYPE 2 DIABETICS
Journal of Experimental and Clinical Medicine
2022-Cilt: 39 - Sayı: 3
798-802
C peptide,
Diabetes,
Obesity,
GLP-1 receptor agonist,
Exenatide
75
106